Kite’s groundbreaking CAR-T hits key study goal, heads to the FDA
Kite Pharma is going for it.
Now well out in front of its CAR-T rivals, Kite Pharma $KITE has gathered a promising set of interim …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
